Entrada Therapeutics, Inc. (TRDA) Ownership

$10.28

$0.21 (2.04%)
Last update: 03:56 PM EST
Day's range
$9.52
Day's range
$10.33

Entrada Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 11/14/2025 4.87 M $28.22 M   0.00% 11.77%
MPM ASSET MANAGEMENT LLC 11/14/2025 4.38 M $25.41 M   0.00% 10.60%
5AM VENTURE MANAGEMENT, LLC 11/14/2025 4.26 M $24.69 M   -1.21% 10.30%
BLACKROCK, INC. 11/12/2025 2.04 M $11.86 M   1.08% 4.94%
VANGUARD GROUP INC 11/07/2025 1.60 M $9.30 M   -0.04% 3.88%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 954.42 K $5.54 M   -10.02% 2.31%
MILLENNIUM MANAGEMENT LLC 11/14/2025 836.61 K $4.85 M   391.19% 2.02%
STEPSTONE GROUP LP 11/14/2025 761.28 K $4.42 M   0.00% 1.84%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 645.12 K $3.74 M   2.15% 1.56%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 594.30 K $3.45 M   56.60% 1.44%
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 584.96 K $3.39 M   0.00% 1.42%
STATE STREET CORP 11/14/2025 498.62 K $2.89 M   0.56% 1.21%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 394.28 K $2.29 M   -7.01% 0.95%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 360.53 K $2.09 M   -85.96% 0.87%
MORGAN STANLEY 11/14/2025 346.76 K $2.01 M   112.61% 0.84%
ROYCE & ASSOCIATES LP 11/12/2025 345.51 K $2.00 M   54.76% 0.84%
CITADEL ADVISORS LLC 11/14/2025 335.74 K $1.95 M   234.55% 0.81%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 315.81 K $1.83 M   43.07% 0.76%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 297.94 K $1.72 M   550.45% 0.72%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 287.87 K $1.67 M   115.26% 0.70%
NORTHERN TRUST CORP 11/14/2025 253.61 K $1.47 M   -15.55% 0.61%
JANE STREET GROUP, LLC 11/14/2025 247.52 K $1.44 M   383.83% 0.60%
GOLDMAN SACHS GROUP INC 11/14/2025 222.34 K $1.29 M   164.21% 0.54%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 185.26 K $1.07 M   -9.05% 0.45%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 148.21 K $859.63 K   4,767.39% 0.36%
JPMORGAN CHASE & CO 11/26/2025 133.88 K $776.49 K   734.96% 0.32%
ALGERT GLOBAL LLC 11/14/2025 129.81 K $753.00 K   100.00% 0.31%
BANK OF AMERICA CORP /DE/ 11/14/2025 126.45 K $733.40 K   246.69% 0.31%
TREXQUANT INVESTMENT LP 11/14/2025 122.87 K $712.62 K   1,061.62% 0.30%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 122.68 K $711.52 K   100.00% 0.30%
BANK OF NEW YORK MELLON CORP 11/03/2025 105.81 K $613.68 K   7.93% 0.26%
MOORE CAPITAL MANAGEMENT, LP 11/14/2025 105.00 K $609.00 K   0.00% 0.25%
WALLEYE CAPITAL LLC 11/14/2025 96.68 K $560.75 K   455.35% 0.23%
TWO SIGMA INVESTMENTS, LP 11/14/2025 93.19 K $540.53 K   100.00% 0.23%
XTX TOPCO LTD 11/14/2025 93.08 K $539.86 K   100.00% 0.23%
AMERICAN CENTURY COMPANIES INC 11/12/2025 75.39 K $437.29 K   0.40% 0.18%
D. E. SHAW & CO., INC. 11/14/2025 71.55 K $414.98 K   100.00% 0.17%
AMERIPRISE FINANCIAL INC 11/14/2025 69.93 K $405.57 K   55.58% 0.17%
CANTOR FITZGERALD, L. P. 12/01/2025 67.33 K $3.91 M   100.00% 0.16%
BARCLAYS PLC 11/12/2025 60.63 K $351.65 K   4.39% 0.15%
QUANTINNO CAPITAL MANAGEMENT LP 11/14/2025 58.23 K $337.73 K   212.69% 0.14%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/14/2025 56.93 K $330.21 K   1.98% 0.14%
NUVEEN, LLC 11/12/2025 56.42 K $327.21 K   0.00% 0.14%
GSA CAPITAL PARTNERS LLP 11/07/2025 55.96 K $325.00 K   100.00% 0.14%
LOS ANGELES CAPITAL MANAGEMENT LLC 10/20/2025 52.08 K $302.06 K   16.69% 0.13%
TWO SIGMA ADVISERS, LP 11/14/2025 51.50 K $298.70 K   100.00% 0.12%
NAN FUNG GROUP HOLDINGS LTD 11/13/2025 49.08 K $284.68 K   0.00% 0.12%
ROYAL BANK OF CANADA 11/14/2025 42.14 K $245.00 K   117.86% 0.10%
GREAT LAKES ADVISORS, LLC 11/03/2025 41.03 K $237.97 K   100.00% 0.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 40.00 K $232.00 K   100.00% 0.10%

Entrada Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 135 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 4.87 M

MPM ASSET MANAGEMENT LLC: 4.38 M

5AM Venture Management, LLC: 4.26 M

BlackRock, Inc.: 2.04 M

VANGUARD GROUP INC: 1.6 M

WELLINGTON MANAGEMENT GROUP LLP: 954,419

68.88% of Entrada Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 30.29 M shares in the last 24 months. This purchase volume represents approximately $311.71 M in transactions.